AU Stock MarketDetailed Quotes

PAR Paradigm Biopharmaceuticals Ltd

Watchlist
  • 0.280
  • -0.010-3.45%
20min DelayMarket Closed Jul 2 16:00 AET
98.10MMarket Cap-1564P/E (Static)

Paradigm Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
Total revenue
-40.98%46.76K
285.52%79.22K
20.55K
Operating revenue
-40.98%46.76K
285.52%79.22K
--20.55K
----
----
----
----
----
Cost of revenue
-86.90%18.83K
45.00%143.75K
99.14K
Gross profit
143.29%27.93K
17.89%-64.53K
-78.59K
Operating expense
25.33%60.07M
10.65%47.93M
152.21%43.31M
67.98%17.17M
14.33%10.22M
45.61%8.94M
42.12%6.14M
4.32M
Selling and administrative expenses
-17.26%6.56M
-9.30%7.93M
109.96%8.75M
79.71%4.17M
-0.58%2.32M
23.30%2.33M
30.39%1.89M
--1.45M
-General and administrative expense
-17.26%6.56M
-9.30%7.93M
109.96%8.75M
79.71%4.17M
-0.58%2.32M
23.30%2.33M
30.39%1.89M
--1.45M
Research and development costs
35.03%52.68M
16.39%39.01M
161.98%33.52M
62.01%12.79M
19.75%7.9M
55.79%6.59M
47.59%4.23M
--2.87M
Depreciation amortization depletion
----
-70.98%60.97K
-1.44%210.06K
2,452.92%213.12K
-45.62%8.35K
-7.67%15.35K
555.90%16.63K
--2.54K
-Depreciation and amortization
----
-70.98%60.97K
-1.44%210.06K
2,452.92%213.12K
-45.62%8.35K
-7.67%15.35K
555.90%16.63K
--2.54K
Other operating expenses
-10.47%822.7K
9.80%918.86K
--836.88K
----
----
----
----
----
Operating profit
-25.10%-60.04M
-10.60%-47.99M
-152.66%-43.39M
-67.98%-17.17M
-14.33%-10.22M
-45.61%-8.94M
-42.12%-6.14M
-4.32M
Net non-operating interest income (expenses)
5,897.84%1.39M
-86.52%23.11K
-82.21%171.4K
268.15%963.48K
385.56%261.71K
110.37%53.9K
-75.26%25.62K
103.57K
Non-operating interest income
2,610.61%1.4M
-75.26%51.74K
-79.04%209.13K
281.20%997.65K
385.56%261.71K
110.37%53.9K
-75.26%25.62K
--103.57K
Non-operating interest expense
-42.67%16.42K
-24.09%28.63K
10.40%37.72K
--34.17K
----
----
----
----
Other net income (expenses)
-22.12%6.74M
-0.63%8.66M
135.60%8.71M
165.17%3.7M
-311.52%-5.67M
47.12%2.68M
41.28%1.82M
1.29M
Special income (charges)
----
----
----
----
---6.93M
----
----
----
-Less:Impairment of capital assets
----
----
----
----
--6.93M
----
----
----
Other non-operating income (expenses)
-22.12%6.74M
-0.63%8.66M
135.60%8.71M
194.66%3.7M
-53.22%1.25M
47.12%2.68M
41.28%1.82M
--1.29M
Income before tax
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-152.45%-15.63M
-44.79%-6.19M
-46.20%-4.28M
-2.92M
Income tax
0
0
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-152.45%-15.63M
-44.79%-6.19M
-46.20%-4.28M
-2.92M
Net income continuous operations
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-152.45%-15.63M
-44.79%-6.19M
-46.20%-4.28M
---2.92M
Noncontrolling interests
Net income attributable to the company
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-152.45%-15.63M
-44.79%-6.19M
-46.20%-4.28M
-2.92M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-32.26%-51.91M
-14.44%-39.25M
-178.86%-34.3M
21.30%-12.3M
-152.45%-15.63M
-44.79%-6.19M
-46.20%-4.28M
-2.92M
Diluted earnings per share
-9.98%-0.1792
-0.78%-0.1629
-173.53%-0.1616
44.01%-0.0591
-99.37%-0.1055
-22.15%-0.0529
-24.17%-0.0433
-0.0349
Basic earnings per share
-9.98%-0.1792
-0.78%-0.1629
-173.53%-0.1616
44.01%-0.0591
-99.37%-0.1055
-22.15%-0.0529
-24.17%-0.0433
-0.0349
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016
Total revenue -40.98%46.76K285.52%79.22K20.55K
Operating revenue -40.98%46.76K285.52%79.22K--20.55K--------------------
Cost of revenue -86.90%18.83K45.00%143.75K99.14K
Gross profit 143.29%27.93K17.89%-64.53K-78.59K
Operating expense 25.33%60.07M10.65%47.93M152.21%43.31M67.98%17.17M14.33%10.22M45.61%8.94M42.12%6.14M4.32M
Selling and administrative expenses -17.26%6.56M-9.30%7.93M109.96%8.75M79.71%4.17M-0.58%2.32M23.30%2.33M30.39%1.89M--1.45M
-General and administrative expense -17.26%6.56M-9.30%7.93M109.96%8.75M79.71%4.17M-0.58%2.32M23.30%2.33M30.39%1.89M--1.45M
Research and development costs 35.03%52.68M16.39%39.01M161.98%33.52M62.01%12.79M19.75%7.9M55.79%6.59M47.59%4.23M--2.87M
Depreciation amortization depletion -----70.98%60.97K-1.44%210.06K2,452.92%213.12K-45.62%8.35K-7.67%15.35K555.90%16.63K--2.54K
-Depreciation and amortization -----70.98%60.97K-1.44%210.06K2,452.92%213.12K-45.62%8.35K-7.67%15.35K555.90%16.63K--2.54K
Other operating expenses -10.47%822.7K9.80%918.86K--836.88K--------------------
Operating profit -25.10%-60.04M-10.60%-47.99M-152.66%-43.39M-67.98%-17.17M-14.33%-10.22M-45.61%-8.94M-42.12%-6.14M-4.32M
Net non-operating interest income (expenses) 5,897.84%1.39M-86.52%23.11K-82.21%171.4K268.15%963.48K385.56%261.71K110.37%53.9K-75.26%25.62K103.57K
Non-operating interest income 2,610.61%1.4M-75.26%51.74K-79.04%209.13K281.20%997.65K385.56%261.71K110.37%53.9K-75.26%25.62K--103.57K
Non-operating interest expense -42.67%16.42K-24.09%28.63K10.40%37.72K--34.17K----------------
Other net income (expenses) -22.12%6.74M-0.63%8.66M135.60%8.71M165.17%3.7M-311.52%-5.67M47.12%2.68M41.28%1.82M1.29M
Special income (charges) -------------------6.93M------------
-Less:Impairment of capital assets ------------------6.93M------------
Other non-operating income (expenses) -22.12%6.74M-0.63%8.66M135.60%8.71M194.66%3.7M-53.22%1.25M47.12%2.68M41.28%1.82M--1.29M
Income before tax -32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-152.45%-15.63M-44.79%-6.19M-46.20%-4.28M-2.92M
Income tax 00000000
Earnings from equity interest net of tax
Net income -32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-152.45%-15.63M-44.79%-6.19M-46.20%-4.28M-2.92M
Net income continuous operations -32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-152.45%-15.63M-44.79%-6.19M-46.20%-4.28M---2.92M
Noncontrolling interests
Net income attributable to the company -32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-152.45%-15.63M-44.79%-6.19M-46.20%-4.28M-2.92M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -32.26%-51.91M-14.44%-39.25M-178.86%-34.3M21.30%-12.3M-152.45%-15.63M-44.79%-6.19M-46.20%-4.28M-2.92M
Diluted earnings per share -9.98%-0.1792-0.78%-0.1629-173.53%-0.161644.01%-0.0591-99.37%-0.1055-22.15%-0.0529-24.17%-0.0433-0.0349
Basic earnings per share -9.98%-0.1792-0.78%-0.1629-173.53%-0.161644.01%-0.0591-99.37%-0.1055-22.15%-0.0529-24.17%-0.0433-0.0349
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg